Učitavanje...

Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women

Objective: To investigate the efficacy, safety, and dose response of three doses of ibandronate, given intermittently by intravenous (IV) injection every three months, in preventing postmenopausal osteoporosis. Patients and methods: 629 postmenopausal women, categorised according to time since menop...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Stakkestad, J, Benevolenskaya, L, Stepan, J, Skag, A, Nordby, A, Oefjord, E, Burdeska, A, Jonkanski, I, Mahoney, P
Format: Artigo
Jezik:Inglês
Izdano: 2003
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1754320/
https://ncbi.nlm.nih.gov/pubmed/12972476
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.62.10.969
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!